Breast cancer
Open
Phase 3
This trial is looking at a drug called abemaciclib for women whose hormone therapy might not work so well.
The trial is for women who:
have and are due to start treatment
who have been through the
Cancer Research UK supports this trial.
Recruitment start: 26 November 2020
Recruitment end: 30 September 2026
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Professor Stephen Johnston
Cancer Research UK
Institute of Cancer Research (ICR)
Lilly Oncology
This is CRUK trial number CRUKE/19/008.
The Institute of Cancer Research have made a short video about the treatment part of the trial (part 2). You can watch it here.(link is external)
Last reviewed: 28 February 2025
CRUK internal database number: 17362